医疗机构药品集中招标采购中的监督管理亟待加强  

Supervising of the Centralized Public Bidding in Drug Purchasing of Medical Institution Should be Strengthened Urgently

作　　者：韩希成 

机构地区：[1]陕西省宝鸡市医药总公司,宝鸡市721000

出　　处：《中国药房》2005年第13期964-966,共3页China Pharmacy

摘　　要：目的:规范医疗机构药品集中招标采购行为,促进医药行业健康发展。方法:分析医疗单位、供货企业、中介机构、监管部门4个方面在药品集中招标采购中存在的问题,并提出相应的对策和措施。结果与结论:药品集中招标采购牵涉面广,需要调整好各方利益,尤其是加强监督管理力度,方能真正达到“阳光采购”的目的,保证医疗机构药品集中招标采购顺利、有序进行。OBJECTIVE:To regulate centralized public bidding activity in the drug purchasing of medical institution and to promote the sound development of the pharmaceutical industry.METHODS:The problems in the public bidding of drug purchasing of the medical institutions,drug suppliers,medium agencies and monitoring departments were analyzed and some related countermeasures were put forward.RESULTS&CONCLUSION:A variety of groups are involved in the public bidˉding of drug purchasing,whose interests should be regulated well.It is especially needed to strengthen the supervising in the public bidding so as to ensure the carrying out of the“Sunshine Purchasing”policy and guarantee the smoothly and orderly operation of the public bidding in the drug purchasing.

关 键 词：医疗机构药品集中招标采购 存在问题 监督管理 

分 类 号：R95[医药卫生—药学]